Symbol
| SLC18A3
| contributors: mct/npt - updated : 12-07-2010
|
HGNC name
| solute carrier family 18 (vesicular acetylcholine), member 3
|
HGNC id
| 10936
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --low
|  
|
in breast cancer | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
| | | |
| VAChT mutant mice have decreased left ventricle function associated with altered calcium handling, and phenotype was attributable to reduced cholinergic tone, since administration of the cholinesterase inhibitor pyridostigmine for 2 weeks reversed the cardiac phenotype in mutant mice (Lara 2010) |